cardiotonic agents (Gwangju)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Namecardiotonic agents (Gwangju)
Drug Alias NamePKC zeta inhibitors (Gwangju)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C zeta inhibitors
TargetsProtein kinase C zeta
Therapy Area/IndicationsInflammationFibrosisHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGwangju Institute of Science and Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGwangju Institute of Science and Technology
Active IndicationsN/A
Inactive IndicationsInflammationFibrosisHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A